%0 Journal Article
%A Yang, Keyi
%A Doege, Daniela
%A Thong, Melissa S Y
%A Koch-Gallenkamp, Lena
%A Weisser, Linda
%A Bertram, Heike
%A Eberle, Andrea
%A Holleczek, Bernd
%A Nennecke, Alice
%A Waldmann, Annika
%A Zeissig, Sylke Ruth
%A Pritzkuleit, Ron
%A Jansen, Lina
%A Brenner, Hermann
%A Arndt, Volker
%T Diabetes mellitus in long-term survivors with colorectal, breast, or prostate cancer: Prevalence and prognosis. A population-based study.
%J Cancer
%V 130
%N 7
%@ 0008-543X
%C New York, NY
%I Wiley-Liss
%M DKFZ-2023-02446
%P 1158-1170
%D 2024
%Z #EA:C071#LA:C071# / 2024 Apr 1;130(7):1158-1170
%X Patients with cancer are at increased risk of diabetes mellitus (DM). Previous studies on the prevalence and prognostic impact of DM in cancer survivors were limited by small sample sizes or short follow-up times. We aimed to compare the patient-reported prevalence of DM in long-term cancer survivors (LTCS), who survived 5 years or more after cancer diagnosis, with that in cancer-free controls, and to estimate the mortality risk among LTCS according to DM status.Our population-based cohort comprised 6952 LTCS diagnosed with breast, colorectal, or prostate cancer between 1994 and 2004, recruited in 2008-2011 (baseline), and followed until 2019. A total of 1828 cancer-free individuals served as controls. Multivariable logistic regression was used to compare the prevalence of DM in LTCS and controls, and according to covariates at baseline. Mortality among LTCS according to DM was assessed by Cox proportional hazards regression.A total of 962 (13.8
%K cancer survivors (Other)
%K control group (Other)
%K diabetes mellitus (Other)
%K mortality (Other)
%K prevalence (Other)
%F PUB:(DE-HGF)16
%9 Journal Article
%$ pmid:37996981
%R DOI:10.1002/cncr.35133
%U https://inrepo02.dkfz.de/record/285584